The 'dnet' approach promotes emerging research on cancer patient survival

Genome Medicine

Volumn 6, Issue 8, 2014, Pages

  Fang, Hai ^a   Gough, Julian ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLYCOPROTEIN; PROTEIN TYROSINE KINASE;

ACUTE GRANULOCYTIC LEUKEMIA; ANALYTIC METHOD; APOPTOSIS; ARTICLE; BLADDER CARCINOMA; BREAST ADENOCARCINOMA; CANCER GENETICS; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CELL ADHESION; COLORECTAL CARCINOMA; CYTOSKELETON; DATA ANALYSIS; DNA REPAIR; ENDOMETRIUM CARCINOMA; GENE IDENTIFICATION; GENE MAPPING; GENE MUTATION; GENE NETWORK; GENE SET ENRICHMENT ANALYSIS; GENETIC DATABASE; GENOMICS; GLIOBLASTOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; KIDNEY CARCINOMA; LUNG ADENOCARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; MICROTUBULE; MOLECULAR EVOLUTION; ONTOLOGY; OVARY CARCINOMA; RANDOMIZATION; TRANSITIONAL CELL CARCINOMA;

EID: 84908327053     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/s13073-014-0064-8     Document Type: Article

References (42)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674. 10.1016/j.cell.2011.02.013, 21376230.
2. Auffray C, Chen Z, Hood L. Systems medicine: the future of medical genomics and healthcare. Genome Med 2009, 1:2. 10.1186/gm2, 19348689.
3. Garraway LA. Genomics-driven oncology: framework for an emerging paradigm. J Clin Oncol 2013, 31:1806-1814. 10.1200/JCO.2012.46.8934, 23589557.
4. Ashworth A, Hudson TJ. Genomics: Comparisons across cancers. Nature 2013, 502:306-307. 10.1038/502306a, 24132284.
5. Engström PG, Tommei D, Stricker SH, Ender C, Pollard SM, Bertone P. Digital transcriptome profiling of normal and glioblastoma-derived neural stem cells identifies genes associated with patient survival. Genome Med 2012, 4:76. 10.1186/gm377, 23046790.
6. Konstantinopoulos PA, Spentzos D, Cannistra SA. Gene-expression profiling in epithelial ovarian cancer. Nat Clin Pract Oncol 2008, 5:577-587. 10.1038/ncponc1178, 18648354.
7. Reis-Filho JS, Pusztai L. Gene expression profiling in breast cancer: classification, prognostication, and prediction. Lancet 2011, 378:1812-1823. 10.1016/S0140-6736(11)61539-0, 22098854.
8. Valk PJM, Verhaak RGW, Beijen MA, Erpelinck CAJ, Barjesteh Van Waalwijk van Doorn-Khosrovani S, Boer JM, Beverloo HB, Moorhouse MJ, van der Spek PJ, Löwenberg B, Delwel R. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004, 350:1617-1628. 10.1056/NEJMoa040465, 15084694.
9. Konstantinopoulos PA, Spentzos D, Karlan BY, Taniguchi T, Fountzilas E, Francoeur N, Levine DA, Cannistra SA. Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer. J Clin Oncol 2010, 28:3555-3561. 10.1200/JCO.2009.27.5719, 20547991.
10. Hofree M, Shen JP, Carter H, Gross A, Ideker T. Network-based stratification of tumor mutations. Nat Methods 2013, 10:1108-1115. 10.1038/nmeth.2651, 24037242.
11. Weinstein JN, Collisson EA, Mills GB, Shaw KRM, Ozenberger BA, Ellrott K, Shmulevich I, Sander C, Stuart JM. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet 2013, 45:1113-1120. 10.1038/ng.2764, 24071849.
12. Package 'dnet'. []., http://cran.r-project.org/package=dnet
13. Csardi G, Nepusz T. The igraph software package for complex network research. InterJournal Complex Syst 2006, 1695:1695.
14. Fang H, Gough J. supraHex: An R/Bioconductor package for tabular omics data analysis using a supra-hexagonal map. Biochem Biophys Res Commun 2014, 443:285-289. 10.1016/j.bbrc.2013.11.103, 24309102.
15. Demo for TCGA mutation and survival dataset. []., http://supfam.org/dnet/demo-TCGA.html
16. Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, Xie M, Zhang Q, McMichael JF, Wyczalkowski MA, Leiserson MDM, Miller CA, Welch JS, Walter MJ, Wendl MC, Ley TJ, Wilson RK, Raphael BJ, Ding L. Mutational landscape and significance across 12 major cancer types. Nature 2013, 502:333-339. 10.1038/nature12634, 24132290.
17. TCGA mutational profiles. []., http://supfam.org/dnet/TCGA_mutations.html
18. Package 'survival'. []., http://cran.r-project.org/package=survival
19. Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C, Jensen LJ. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res 2013, 41:D808-D815. 10.1093/nar/gks1094, 23203871.
20. Dittrich MT, Klau GW, Rosenwald A, Dandekar T, Muller T. Identifying functional modules in protein-protein interaction networks: an integrated exact approach. Bioinformatics 2008, 24:i223-i231. 10.1093/bioinformatics/btn161, 18586718.
21. Erten S, Bebek G, Ewing RM, Koyutürk M. DADA: Degree-aware algorithms for network-based disease gene prioritization. BioData Min 2011, 4:19. 10.1186/1756-0381-4-19, 21699738.
22. Fang H, Gough J. A disease-drug-phenotype matrix inferred by walking on a functional domain network. Mol Biosyst 2013, 9:1686-1696. 10.1039/c3mb25495j, 23462907.
23. Pounds S, Morris SW. Estimating the occurrence of false positives and false negatives in microarray studies by approximating and partitioning the empirical distribution of p-values. Bioinformatics 2003, 19:1236-1242. 10.1093/bioinformatics/btg148, 12835267.
24. Ideker T, Ozier O, Schwikowski B, Siegel AF. Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics 2002, 18:S233-S240. 10.1093/bioinformatics/18.suppl_1.S233, 12169552.
25. Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, Workman C, Christmas R, Avila-Campilo I, Creech M, Gross B, Hanspers K, Isserlin R, Kelley R, Killcoyne S, Lotia S, Maere S, Morris J, Ono K, Pavlovic V, Pico AR, Vailaya A, Wang P-L, Adler A, Conklin BR, Hood L, Kuiper M, Sander C, Schmulevich I, Schwikowski B, Warner GJ, et al. Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2007, 2:2366-2382. 10.1038/nprot.2007.324, 17947979.
26. Griffith M, Griffith OL, Coffman AC, Weible JV, McMichael JF, Spies NC, Koval J, Das I, Callaway MB, Eldred JM, Miller CA, Subramanian J, Govindan R, Kumar RD, Bose R, Ding L, Walker JR, Larson DE, Dooling DJ, Smith SM, Ley TJ, Mardis ER, Wilson RK. DGIdb: mining the druggable genome. Nat Methods 2013, 10:1209-1210. 10.1038/nmeth.2689, 24122041.
27. Fang H, Gough J. A domain-centric solution to functional genomics via dcGO Predictor. BMC Bioinformatics 2013, 14:S9. 23514627.
28. Fang H, Gough J. dcGO: database of domain-centric ontologies on functions, phenotypes, diseases and more. Nucleic Acids Res 2013, 41:D536-D544. 10.1093/nar/gks1080, 23161684.
29. Fang H, Oates ME, Pethica RB, Greenwood JM, Sardar AJ, Rackham OJL, Donoghue PCJ, Stamatakis A, De Lima Morais DA, Gough J. A daily-updated tree of (sequenced) life as a reference for genome research. Sci Rep 2013, 3:2015. 23778980.
30. De Lima Morais DA, Fang H, Rackham OJ, Wilson D, Pethica R, Chothia C, Gough J. SUPERFAMILY 1.75 including a domain-centric gene ontology method. Nucleic Acids Res 2011, 39:D427-D434. 10.1093/nar/gkq1130, 21062816.
31. Zhang W, Ota T, Shridhar V, Chien J, Wu B, Kuang R. Network-based survival analysis reveals subnetwork signatures for predicting outcomes of ovarian cancer treatment. PLoS Comput Biol 2013, 9:e1002975. 10.1371/journal.pcbi.1002975, 23555212.
32. Wu G, Stein L. A network module-based method for identifying cancer prognostic signatures. Genome Biol 2012, 13:R112. 10.1186/gb-2012-13-12-r112, 23228031.
33. Ma S, Huang Y, Huang J, Fang K. Gene network-based cancer prognosis analysis with sparse boosting. Genet Res (Camb) 2012, 94:205-221. 10.1017/S0016672312000419.
34. Shi M, Beauchamp RD, Zhang B. A network-based gene expression signature informs prognosis and treatment for colorectal cancer patients. PLoS One 2012, 7:e41292. 10.1371/journal.pone.0041292, 22844451.
35. Vandin F, Clay P, Upfal E, Raphael BJ: Discovery of mutated subnetworks associated with clinical data in cancer.Pacific Symp Biocomput 2012, 55-66..
36. Leung A, Bader GD, Reimand J. HyperModules: identifying clinically and phenotypically significant network modules with disease mutations for biomarker discovery. Bioinformatics 2014, 30:2230-2232. 10.1093/bioinformatics/btu172, 24713437.
37. Network CGA. Comprehensive molecular portraits of human breast tumours. Nature 2012, 490:61-70. 10.1038/nature11453.
38. Network CGA. Integrated genomic characterization of endometrial carcinoma. Nature 2013, 497:67-73. 10.1038/nature12113.
39. sTOL. []., http://supfam.org/SUPERFAMILY/sTOL
40. Domazet-Loso T, Tautz D. Phylostratigraphic tracking of cancer genes suggests a link to the emergence of multicellularity in metazoa. BMC Biol 2010, 8:66. 10.1186/1741-7007-8-66, 20492640.
41. Deuterostome. []., http://en.wikipedia.org/wiki/Deuterostome
42. Fernandez-Zapico ME, Gonzalez-Paz NC, Weiss E, Savoy DN, Molina JR, Fonseca R, Smyrk TC, Chari ST, Urrutia R, Billadeau DD. Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis. Cancer Cell 2005, 7:39-49. 10.1016/j.ccr.2004.11.024, 15652748.